Pierre Raboisson

Countries

This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.

Institutions

• Janssen (Belgium)21.9%
• Inserm8.9%
• Amgen (United States)7.6%
• KU Leuven6.9%
• Janssen (United States)6.9%
• Merck & Co., Inc., Rahway, NJ, USA (United States)5.9%
• Other41.8%

Fields

• Medicine74.8%
• Biochemistry, Genetics and Molecular Biology10.9%
• Computer Science6.8%
• Chemistry3.8%
• Pharmacology, Toxicology and Pharmaceutics1.4%
• Agricultural and Biological Sciences1.1%
• Other1.2%

Topics

• Hepatitis C virus research12.7%
• Computational Drug Discovery Methods10.2%
• SARS-CoV-2 and COVID-19 Research9.8%
• Mosquito-borne diseases and control8.5%
• Respiratory viral infections research8.3%
• Hepatitis B Virus Studies7.3%
• Other43.2%